scispace - formally typeset
H

Herbert Herzog

Researcher at Garvan Institute of Medical Research

Publications -  361
Citations -  24072

Herbert Herzog is an academic researcher from Garvan Institute of Medical Research. The author has contributed to research in topics: Neuropeptide Y receptor & Receptor. The author has an hindex of 72, co-authored 348 publications receiving 22247 citations. Previous affiliations of Herbert Herzog include University of Sydney & University of New South Wales.

Papers
More filters
Journal ArticleDOI

Gut hormone PYY 3-36 physiologically inhibits food intake

TL;DR: In this paper, the authors showed that post-prandial elevation of PYY3-36 may act through the arcuate nucleus Y2R to inhibit feeding in a gut-hypothalamic pathway.
Journal Article

BRIEF COMMUNICATION ARISING: Gut hormone PYY3-36 physiologically inhibits food intake

TL;DR: The authors showed that post-prandial elevation of PYY3-36 may act through the arcuate nucleus Y2R to inhibit feeding in a gut-hypothalamic pathway.
Journal Article

XVI. International Union of Pharmacology Recommendations for the Nomenclature of Neuropeptide Y, Peptide YY, and Pancreatic Polypeptide Receptors

TL;DR: Based on structural and evolutionary criteria, neuropeptide Y (NPY)b, peptide YY (PYY) and pancreatic polypetide (PP) are closely related polypeptides that share considerable amino acid homology, amidated C-terminal ends, and the same structure.
Journal ArticleDOI

Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome

TL;DR: It is reported that stress exaggerates diet-induced obesity through a peripheral mechanism in the abdominal white adipose tissue that is mediated by neuropeptide Y (NPY), and manipulations of NPY2R activity within fat tissue offer new ways to remodel fat and treat obesity and metabolic syndrome.
Journal ArticleDOI

Critical role for peptide YY in protein-mediated satiation and body-weight regulation

TL;DR: It is suggested that modulating the release of endogenous satiety factors, such as PYY, through alteration of specific diet constituents could provide a rational therapy for obesity.